Assignee
ONCOCEUTICS INC
US·13 granted patents·3 pending applications·37 citations·filing 2014–2024
Top patents by PatentIndex Score
16 records- 0194US9376437B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Jun 28, 2016·11 cites·9 claims
- 0292US10172862B2Imipridones for gliomasONCOCEUTICS INC·Filed 2018·Granted Jan 8, 2019·5 cites·9 claims
- 0392US9688679B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Jun 27, 2017·7 cites·4 claims
- 0487US9265765B27-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Feb 23, 2016·10 cites·3 claims
- 0586US10456402B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2018·Granted Oct 29, 2019·1 cites·2 claims
- 0684US10369154B2Imipridones for gliomasONCOCEUTICS INC·Filed 2018·Granted Aug 6, 2019·1 cites·30 claims
- 0783US2024366613A1Impridones for gliomasONCOCEUTICS INC·Filed 2024·Application pending·0 cites
- 0878US10953014B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2019·Granted Mar 23, 2021·0 cites·2 claims
- 0977US10266533B27-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2017·Granted Apr 23, 2019·1 cites·15 claims
- 1074US9845324B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2016·Granted Dec 19, 2017·1 cites·26 claims
- 1173US12102639B2Imipridones for gliomasONCOCEUTICS INC·Filed 2021·Granted Oct 1, 2024·0 cites·19 claims
- 1273US2021154200A17-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2021·Application pending·0 cites
- 1368US10946022B2Imipridones for gliomasONCOCEUTICS INC·Filed 2019·Granted Mar 16, 2021·0 cites·28 claims
- 1466US2019194201A17-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2019·Application pending·0 cites
- 1564US10045992B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 1661US11116771B2G protein-coupled receptor (GPCR) modulation by imipridonesONCOCEUTICS INC·Filed 2017·Granted Sep 14, 2021·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →